NBTX
Nanobiotix S.A.
NASDAQ · Healthcare · Biotechnology · FR
$38.80
−3.00%Leverage
- Debt / equity
- -1.13x
- Net debt / equity
- -0.50x
- Debt / assets
- 1.41x
- Debt / EBITDA
- -1.20x
- Net debt / EBITDA
- -0.54x
Liquidity & coverage
- Current ratio
- 1.09x
- Quick ratio
- 1.09x
- Cash ratio
- 0.92x
- Interest coverage
- -7.62x
- EBITDA / interest
- -7.62x
- Working capital
- $6.1M
Cash & dividend
- FCF / debt
- -0.57x
- Cash flow / debt
- -0.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025